Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients
- 31 December 1990
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (11-12) , 1156-1162
- https://doi.org/10.1016/0277-5379(90)90276-y
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samplesJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patientsBritish Journal of Cancer, 1989
- Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicinCancer Chemotherapy and Pharmacology, 1988
- Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.Journal of Clinical Oncology, 1988
- Experimental Comparative Study on Myelotoxicity of 4′-Deoxy-4′-I-Doxorubicin and of DoxorubicinChemotherapy, 1988
- A phase I study of menogaril in patients with advanced cancer.Journal of Clinical Oncology, 1987
- Comparative in vitro activity of 4?-deoxy-4?-iododoxorubicin and other anthracyclines in the human tumor clonogenic assayInvestigational New Drugs, 1987
- Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: Evidence from metabolites identified in serumEuropean Journal of Cancer and Clinical Oncology, 1986
- A Validation Process for Data from the Analysis of Drugs in Biological FluidsDrug Development and Industrial Pharmacy, 1985
- Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian liversBiochemical Pharmacology, 1978